Evidence
What the research shows
Phase 2 evidence for mitochondrial myopathies. Strong rationale in age-related decline.
Encyclopedia / Longevity
SS-31 (Elamipretide).
Mitochondrial cardiolipin-binding peptide studied for energy and aging.
LongevityMitochondrialSubcutaneous injection
Protocol
Cycle and dosing notes
5 mg daily SC for 4-8 weeks.
Safety
What to watch for
Well tolerated in trials at clinical doses.
Best for
Who benefits most
Longevity / endurance users with mitochondrial concerns.
Not for
Who should avoid it
Cancer history (theoretical mitochondrial promotion of tumor metabolism).
Build your stack
SS-31 (Elamipretide) works best inside a protocol.
Pepzilla matches it with the right companions, dosing, and lifestyle rails for your goals — calibrated in 60 seconds.